Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-09 Purchase |
2024-09-11 5:47 pm |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer |
140,000 | $2.8222 | $395,115 | 384,024 (Direct) |
View |
| 2024-09-09 Purchase |
2024-09-11 5:47 pm |
RELMADA THERAPEUTICS INC. | RLMD | CASAMENTO CHARLES J Director |
13,000 | $2.56 | $33,280 | 13,000 (Direct) |
View |
| 2024-09-09 Purchase |
2024-09-11 5:46 pm |
RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer |
53,432 | $2.8017 | $149,701 | 88,335 (Direct) |
View |
| 2024-09-09 Purchase |
2024-09-11 5:46 pm |
RELMADA THERAPEUTICS INC. | RLMD | Kelly Paul Edward Director |
25,000 | $2.59 | $64,750 | 212,295 (Direct) |
View |
| 2024-01-29 Purchase |
2024-01-31 6:29 pm |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer |
100,000 | $3.8674 | $386,738 | 244,024 (Direct) |
View |
| 2024-01-29 Purchase |
2024-01-31 6:28 pm |
RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer |
32,675 | $3.8475 | $125,717 | 34,903 (Direct) |
View |
| 2024-01-29 Purchase |
2024-01-31 6:28 pm |
RELMADA THERAPEUTICS INC. | RLMD | Ence Chuck CA and CO |
38,970 | $3.8727 | $150,920 | 38,970 (Direct) |
View |
| 2023-05-23 Purchase |
2023-05-24 09:00 am |
RELMADA THERAPEUTICS INC. | RLMD | O'Gorman Cedric Chief Medical Officer |
10,000 | $3.18 | $31,800 | 10,121 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-10-22 Gift |
2024-10-23 4:27 pm |
N/A N/A |
RELMADA THERAPEUTICS INC. | RLMD | CASAMENTO CHARLES J Director |
13,000 | $0 | 0 (Direct) |
View |
| 2024-05-24 Other |
2024-05-29 9:25 pm |
2024-03-15 2033-12-15 |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer |
122,358 | $0 | 490,120 (Direct) |
View |
| 2024-05-24 Option Award |
2024-05-29 9:25 pm |
2024-03-15 2033-12-15 |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer |
122,358 | $0 | 490,120 (Direct) |
View |
| 2024-05-24 Other |
2024-05-29 9:24 pm |
2024-03-15 2033-12-15 |
RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer |
54,624 | $0 | 218,804 (Direct) |
View |
| 2024-05-24 Option Award |
2024-05-29 9:24 pm |
2024-03-15 2033-12-15 |
RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer |
54,624 | $0 | 218,804 (Direct) |
View |
| 2024-05-24 Other |
2024-05-29 9:24 pm |
2024-03-15 2033-12-15 |
RELMADA THERAPEUTICS INC. | RLMD | Kelly Paul Edward Director |
43,700 | $0 | 175,044 (Direct) |
View |
| 2024-05-24 Option Award |
2024-05-29 9:24 pm |
2024-03-15 2033-12-15 |
RELMADA THERAPEUTICS INC. | RLMD | Kelly Paul Edward Director |
43,700 | $0 | 175,044 (Direct) |
View |
| 2024-05-24 Other |
2024-05-29 9:24 pm |
2024-03-15 2033-12-15 |
RELMADA THERAPEUTICS INC. | RLMD | GLASSPOOL JOHN Director |
20,976 | $0 | 84,020 (Direct) |
View |
| 2024-05-24 Option Award |
2024-05-29 9:24 pm |
2024-03-15 2033-12-15 |
RELMADA THERAPEUTICS INC. | RLMD | GLASSPOOL JOHN Director |
20,976 | $0 | 84,020 (Direct) |
View |
| 2024-05-24 Other |
2024-05-29 9:24 pm |
2024-03-15 2033-12-15 |
RELMADA THERAPEUTICS INC. | RLMD | Fedeli Fabiana Director |
20,976 | $0 | 84,020 (Direct) |
View |
| 2024-05-24 Option Award |
2024-05-29 9:24 pm |
2024-03-15 2033-12-15 |
RELMADA THERAPEUTICS INC. | RLMD | Fedeli Fabiana Director |
20,976 | $0 | 84,020 (Direct) |
View |
| 2024-05-24 Other |
2024-05-29 9:23 pm |
2024-03-15 2033-12-15 |
RELMADA THERAPEUTICS INC. | RLMD | Ence Chuck CA and CO |
54,624 | $0 | 218,804 (Direct) |
View |
| 2024-05-24 Option Award |
2024-05-29 9:23 pm |
2024-03-15 2033-12-15 |
RELMADA THERAPEUTICS INC. | RLMD | Ence Chuck CA and CO |
54,624 | $0 | 218,804 (Direct) |
View |
| 2024-05-24 Other |
2024-05-29 9:23 pm |
2024-03-15 2033-12-15 |
RELMADA THERAPEUTICS INC. | RLMD | CASAMENTO CHARLES J Director |
20,976 | $0 | 84,020 (Direct) |
View |
| 2024-05-24 Option Award |
2024-05-29 9:23 pm |
2024-03-15 2033-12-15 |
RELMADA THERAPEUTICS INC. | RLMD | CASAMENTO CHARLES J Director |
20,976 | $0 | 84,020 (Direct) |
View |
| 2023-12-15 Option Award |
2023-12-19 5:28 pm |
2024-03-15 2033-12-15 |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer |
183,881 | $0 | 183,881 (Direct) |
View |
| 2023-12-15 Option Award |
2023-12-19 5:28 pm |
2024-03-15 2033-12-15 |
RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer |
82,090 | $0 | 82,090 (Direct) |
View |
| 2023-12-15 Option Award |
2023-12-19 5:28 pm |
2024-03-15 2033-12-15 |
RELMADA THERAPEUTICS INC. | RLMD | Kelly Paul Edward Director |
65,672 | $0 | 65,672 (Direct) |
View |
| 2023-12-15 Option Award |
2023-12-19 5:27 pm |
2024-03-15 2033-12-15 |
RELMADA THERAPEUTICS INC. | RLMD | GLASSPOOL JOHN Director |
31,522 | $0 | 31,522 (Direct) |
View |
| 2023-12-15 Option Award |
2023-12-19 5:27 pm |
2024-03-15 2033-12-15 |
RELMADA THERAPEUTICS INC. | RLMD | Fedeli Fabiana Director |
31,522 | $0 | 31,522 (Direct) |
View |
| 2023-12-15 Option Award |
2023-12-19 5:27 pm |
2024-03-15 2033-12-15 |
RELMADA THERAPEUTICS INC. | RLMD | Ence Chuck Chief Accounting and CO |
82,090 | $0 | 82,090 (Direct) |
View |
| 2023-12-15 Option Award |
2023-12-19 5:26 pm |
2024-03-15 2033-12-15 |
RELMADA THERAPEUTICS INC. | RLMD | CASAMENTO CHARLES J Director |
31,522 | $0 | 31,522 (Direct) |
View |
| 2023-05-25 Option Award |
2023-05-30 5:10 pm |
2022-12-16 2032-12-16 |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer |
527,211 | $0 | 850,728 (Direct) |
View |
| 2023-05-25 Option Award |
2023-05-30 5:09 pm |
2023-03-16 2032-12-16 |
RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged Chief Financial Officer |
317,643 | $0 | 512,560 (Direct) |
View |
| 2023-05-25 Option Award |
2023-05-30 5:09 pm |
2023-03-16 2032-12-16 |
RELMADA THERAPEUTICS INC. | RLMD | SCHMIDT ERIC THOMAS Director |
92,958 | $0 | 150,000 (Direct) |
View |
| 2023-05-25 Option Award |
2023-05-30 5:08 pm |
2023-03-16 2032-12-16 |
RELMADA THERAPEUTICS INC. | RLMD | Kelly Paul Edward Director |
92,958 | $0 | 150,000 (Direct) |
View |
| 2023-05-25 Option Award |
2023-05-30 5:08 pm |
2023-03-16 2032-12-16 |
RELMADA THERAPEUTICS INC. | RLMD | GLASSPOOL JOHN Director |
92,958 | $0 | 150,000 (Direct) |
View |
| 2023-05-25 Option Award |
2023-05-30 5:06 pm |
2024-01-12 2033-01-12 |
RELMADA THERAPEUTICS INC. | RLMD | Fedeli Fabiana Director |
200,000 | $0 | 200,000 (Direct) |
View |
| 2023-05-25 Option Award |
2023-05-30 5:06 pm |
2022-12-16 2032-12-16 |
RELMADA THERAPEUTICS INC. | RLMD | Ence Chuck CA and CO |
321,238 | $0 | 518,361 (Direct) |
View |
| 2023-05-25 Option Award |
2023-05-30 5:05 pm |
2023-03-16 2032-12-16 |
RELMADA THERAPEUTICS INC. | RLMD | CASAMENTO CHARLES J Director |
92,958 | $0 | 150,000 (Direct) |
View |
| 2021-07-08 Ownership(A) |
2023-02-06 5:39 pm |
N/A 2022-07-10 |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
351,985 | $0 | 777,934 (Direct) |
View |
| 2021-07-08 Ownership |
2023-02-02 5:01 pm |
N/A 2022-07-10 |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO CEO |
351,985 | $0 | 552,934 (Direct) |
View |
| 2021-07-08 Ownership |
2023-02-02 5:00 pm |
N/A 2025-11-12 |
RELMADA THERAPEUTICS INC. | RLMD | Kelly Paul Edward Director |
100,000 | $0 | 356,441 (Direct) |
View |
| 2021-12-03 Ownership |
2023-02-02 5:00 pm |
N/A N/A |
RELMADA THERAPEUTICS INC. | RLMD | CASAMENTO CHARLES J Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-01-06 Option Award |
2023-01-13 5:54 pm |
N/A 2033-01-06 |
RELMADA THERAPEUTICS INC. | RLMD | O'Gorman Cedric Chief Medical Officer |
400,000 | $0 | 400,000 (Direct) |
View |
Ownership |
2023-01-13 5:54 pm |
N/A N/A |
RELMADA THERAPEUTICS INC. | RLMD | O'Gorman Cedric Chief Medical Officer |
0 | $0 | 121 (Direct) |
View |
| 2022-12-16 Other |
2022-12-20 7:31 pm |
N/A 2031-12-17 |
RELMADA THERAPEUTICS INC. | RLMD | TRAVERSA SERGIO Chief Executive Officer |
300,000 | $0 | 0 (Direct) |
View |
| 2022-12-16 Other |
2022-12-20 7:31 pm |
N/A 2031-12-17 |
RELMADA THERAPEUTICS INC. | RLMD | Shenouda Maged CFO |
200,000 | $0 | 0 (Direct) |
View |